LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M
15 Oktober 2024 - 5:45PM
UK Regulatory
LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH
FINANCING OF OVER €100M
Lannion, October 15, 2024 – 17:45 pm
LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S
STRATEGY WITH FINANCING OF OVER €100M
- 55.2m
repayable over 7 years, to reschedule existing loans
- 50m to
be drawn over 3 years to finance acquisitions
The LUMIBIRD Group (FR0000038242 -
LBIRD), the European leader in laser technologies, announces that
it has finalised bank financing of more than €100m to reschedule
its current borrowings, particularly in view of the maturity of its
bond debt, and to finance potential acquisition
opportunities.
The financing round comprises Crédit Agricole
Côte d'Armor (lead bank), Arkéa Banque Entreprises et
Institutionnels, Banque Populaire Grand Ouest, Caisse d'Epargne
Bretagne Pays de Loire and LCL. All these banks are part of
Lumibird's historic banking pool: through this financing, they are
renewing their confidence in the Group's strategy.
This funding consists of two lines:
- 55.2m repayable
over 7 years, to reschedule existing borrowings, particularly in
view of the maturity of its bond debt;
- €50m* that can
be drawn down over 3 years, with 40% repayable at maturity and the
remainder amortisable over a total period of 7 years.
The rate spread applied remains the same as in
the previous round, in December 2020.
Marc Le Flohic, Chairman and CEO of Lumibird,
said: "The renewed confidence shown by our banking partners is
a strong signal at a time when Lumibird needs to demonstrate its
ability to increase profitability.”
*Line not confirmed
Next date : Q3 2024 revenues,
21/10/2024 after close of trading
LUMIBIRD is one of the world's leading laser
specialists. With 50 years' experience and expertise in
solid-state, diode and fibre laser technologies, the Group designs,
manufactures and distributes high-performance laser solutions via
two divisions: Photonics and Medical. The Photonics Division
designs and produces components, lasers and systems for the defence
and space, environment, topography and safety, industrial and
scientific, and medtech markets. The Medical branch designs and
produces medical diagnostic and treatment systems for
ophthalmology.
The result of the merger in October 2017 between the Keopsys and
Quantel Groups, LUMIBIRD, with more than 1,000 employees and over
€203.6m in sales in 2023 is present in Europe, America and
Asia.
LUMIBIRD shares are listed in compartment B of Euronext
Paris. FR0000038242 -
LBIRD www.lumibird.com
LUMIBIRD has been a member of Euronext
Tech Leaders since
2022.
Contacts
LUMIBIRD
Marc Le Flohic
Chairman and Chief Executive Officer
Tel. +33(0) 1 69 29 17 00
info@lumibird.com |
LUMIBIRD
Sonia Rutnam
Chief Financial and Transformation Officer
Tel. +33(0) 1 69 29 17 00
info@lumibird.com |
Calyptus
Mathieu Calleux
Investor Relations
Tel. +33(0) 1 53 65 37 91
lumibird@calyptus.net |
- 241015_ LUMIBIRD_Financement_bancaire_EN
Lumibird (EU:LBIRD)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Lumibird (EU:LBIRD)
Historical Stock Chart
Von Dez 2023 bis Dez 2024